版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Objective VEGF-C is ranked first as a lymphoangiogenic factor, which induces lymphatic proliferation and spread of solid tumors. Lymph node status remains the strongest prognostic factor in a variety of human malignant
2、tumors including uterine cervical carcinomas and lymphnode metastasis is promoted by tumor cell aggressiveness,such as abilities of motility and invasiveness. We examined the correlation between VEGF-C expression and tu
3、mor aggressiveness in cervical carcinomas with respect to clinicopathologic features and patient outcome. Objective To investigate the expression of vascular endothelial growth factor-C(VEGF-C) and its receptor in cervi
4、cal carcinoma tissue and their paratumour tissue in pursuit of their role in tumor metastasis and other clinical significance. Method 48 fresh cervical cancer tissue and their paratumour tissue were examined b
5、y RT-PCR to detected the VEGF-C/KDR/Flt-4mRNA expression. Results There was a significant difference of VEGF-C/KDR /Flt-4mRNA expression between the tumor, paratumour tissue and the normal controls. And there was
6、no significant relationship between VEGF-C mRNA, KDR mRNA or flt-4mRNA expression with the pathological types and clinical stage of invasive carcinoma of cervix.But the expression was significant associating with the gr
7、ade of tumor pathology, lymph node metastasis, tumor size and the invasion of deep muscular layer(p<0.05). Conclusions The result suggest that the VEGF-C may play an important role in the lymph node metastasis and
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 非小細(xì)胞肺癌中VEGF-C及其受體mRNA的表達(dá)與臨床意義.pdf
- CD44V6、VEGF-C在宮頸癌組織中的表達(dá)及臨床意義.pdf
- 宮頸癌患者尿激酶受體的檢測(cè)及其臨床意義.pdf
- LASP1和VEGF-C在宮頸癌中的表達(dá)及意義.pdf
- 子宮頸癌中Ezrin的表達(dá)及其臨床意義.pdf
- VEGF-C及其受體VEGFR-3在膀胱移行細(xì)胞癌中的表達(dá)和臨床意義的初步研究.pdf
- SIRT1在宮頸癌及宮頸癌前病變組織中的表達(dá)及其臨床意義.pdf
- 宮頸癌及上皮內(nèi)病變液基細(xì)胞中VEGF mRNA和Endostatin mRNA的表達(dá)及臨床意義.pdf
- 非小細(xì)胞肺癌外周血HIF-1α、VEGF-C mRNA的表達(dá)及其臨床意義.pdf
- 宮頸癌患者血清VEGF-C、VEGF-D的臨床研究.pdf
- 鼻咽癌中VEGF-C、COX-2、VEGFR-3的表達(dá)及其臨床意義.pdf
- Peroxiredoxin1在宮頸癌組織中的表達(dá)及其臨床意義.pdf
- HDAC4在宮頸癌組織中的表達(dá)及其臨床意義.pdf
- D2-40、VEGF-C在食管鱗狀細(xì)胞癌中的表達(dá)及其臨床意義.pdf
- VEGF-C及其受體FLT-4 mRNA在胃癌組織中的表達(dá).pdf
- FHIT、VEGF-C和Ki-67在CIN、宮頸癌中的表達(dá)及意義.pdf
- 非小細(xì)胞肺癌中EGFR和VEGF-C的表達(dá)及其臨床意義.pdf
- 子宮內(nèi)膜癌中VEGF及其受體KDR的表達(dá)及臨床意義.pdf
- 血管內(nèi)皮生長(zhǎng)因子—C(VEGF-C)及其受體(VEGFR-3)在膀胱癌中的表達(dá)及臨床意義.pdf
- KLK7基因mRNA在子宮頸癌組織的表達(dá)及其臨床意義.pdf
評(píng)論
0/150
提交評(píng)論